Tag: MabThera
Latest articles
No clear benefit of HIV antivirals for COVID-19 patients, says study
There is no clear benefit of HIV antivirals for COVID-19 patients, says new study by the Drug Safety Research Unit (DSRU) in Southampton. It...
Symbiosis secures growth finance
Symbiosis Pharmaceutical Services has secured £1m of growth finance from Allied Irish Bank (GB) to support its 2020 strategy. Symbiosis provides niche, sterile manufacturing services...
Pf Webinars: Shaping healthcare markets to serve real brand purpose
Pf's third FREE webinar in conjunction with Triducive and E4H focuses on shaping healthcare markets to serve real brand purpose. As healthcare markets are evolve...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Landmark deal for cystic fibrosis treatment on NHS
NHS patients in England will be some of the first people in Europe to benefit from a landmark deal for cystic fibrosis treatment. Three in...
Four rooms of change: managing transition
For the UK pharma industry, 2010 is likely to bring change in various forms. How will you cope? OTD’s Andy Cotty explains how, with...
Medical device merger raises competition concerns
The CMA has concluded that the merger of two medical device suppliers could lead to a reduction of competition in the supply of total...